by user | Sep 12, 2019 | Media section
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
by user | Aug 24, 2019 | Media section
Errors in the ordering and interpretation of genetic tests for cancer, as well as in communicating results, are continuing to occur, and a newly published report highlighting some of these errors suggests that the nature of the mistakes are reflective of the rapid...
by user | May 17, 2019 | Beyond BRCA, Media section
In this Quest Diagnostics webinar, My Gene Counsel’s Ellen Matloff describes which patients are candidates for genetic testing, summarizes the types of hereditary cancer testing available for patient management, and discusses the key personal and family history...
by user | May 2, 2019 | Media section
In an effort to address challenges arising from the rapid growth of DTC genetic testing, digital health company My Gene Counsel is partnering with Ambry Genetics in a pilot program designed to confirm the results of DTC genetic tests and help...
by user | Mar 27, 2019 | Media section
My Gene Counsel launched a pilot program this week that will provide education, facilitate genetic counseling, and if needed, offer confirmatory testing to individuals with a personal or family history of cancer who have taken a DTC cancer risk test but still have...
by user | Mar 20, 2019 | Media section
Ambry Genetics and My Gene Counsel partner to offer medical-grade testing designed to confirm results of direct-to-consumer (DTC) genetic tests, as well as “proper” genetic counseling for consumers found to be at high risk for hereditary cancers.
